results obtained from in vivo evaluation using xenografted target tsgh-8301 bladder tumor indicated that the 1g3.10 monoclonal antibody conjugate containing doxorubicin injected 4x , i.p. , significantly inhibited tsgh-8301 bladder tumor growth in nude mice , whereas free monoclonal antibody , free drug and the mixture of both showed only moderate inhibition of tumor growth as compared to the untreated control .
C0005695
bladder tumor
C0013089
doxorubicin